Discover 1,443 paid clinical trials in St. Petersburg, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,443
New
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Location: St. Petersburg FL, Orange City FL, Coral Springs FL,
Sponsor: Paradigm Health
Sex: All
Age: 18+
Code: NCT06605404
Recruiting
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
for
Advanced Solid Tumors
Location: St. Petersburg FL, Miami Beach FL, New Orleans LA
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Sex: All
Age: 18+
Code: NCT05277168
Phase1, Phase2, Recruiting
Study of STP938 (Dencatistat) in Advanced Solid Tumours
for
Solid Tumor
Location: St. Petersburg FL, Dallas TX, San Antonio TX
Sponsor: Step Pharma, SAS
Sex: All
Age: 18+
Code: NCT06297525
Phase1, Recruiting
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
for
Relapsed/Refractory Multiple Myeloma (RRMM)
Location: St. Petersburg FL, Baton Rouge LA, Bethesda MD,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07609940
Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
for
Breast Neoplasms
Location: St. Petersburg FL, Altamonte Springs FL, Daphne AL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07060807
Phase3, Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
for
Patients With Non-Small Cell Lung Cancer
Location: St. Petersburg FL, Trinity FL, Saint Augustine FL,
Sponsor: OSE Immunotherapeutics
Sex: All
Age: 18+
Code: NCT06472245
Phase3, Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: St. Petersburg FL, Miami FL, Durham NC, Nashville TN,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase1, Recruiting
CtDNA Based MRD Testing for NAC Monitoring in TNBC
for
TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
Location: St. Petersburg FL, Miami Beach FL, New Orleans LA,
Sponsor: Personalis Inc.
Sex: Female
Age: 18+
Code: NCT06230185
Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: St. Petersburg FL, Orlando FL, Ocala FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06119581
Phase3, Recruiting
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
for
Uncontrolled Gout
Location: Pinellas Park FL, Bay Pines FL, Tampa FL,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT07388498
Phase3, Recruiting
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
for
Proteinuric Kidney Disease
Location: Bay Pines FL, Bradenton FL, Orlando FL, Sanford FL,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 10 - 65
Code: NCT05312879
Phase2, Phase3, Recruiting
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
for
Cutaneous Lupus Erythematosus (CLE),
Location: Clearwater FL, Tampa FL, DeBary FL, Memphis TN,
Sponsor: Ventus Therapeutics U.S., Inc.
Sex: All
Age: 18 - 70+
Code: NCT07260877
Phase2, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)